Henry Bader

Title: The Innovations of Henry Bader

Introduction

Henry Bader is an accomplished inventor based in Canton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on ornithine derivatives. His research has the potential to impact cancer treatment, showcasing the importance of his inventions in the medical field.

Latest Patents

Henry Bader holds a patent for "Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same." This patent describes a new class of ammonium salts of N-acyl derivatives of N-(4-amino-4-deoxypteroyl)-L-ornithine compounds. The ammonium salts provided by this invention exhibit high inhibitory activity against the growth of methotrexate-resistant cells and demonstrate superior chemical stability compared to corresponding acidic N-acyl derivatives.

Career Highlights

Throughout his career, Henry Bader has worked with notable organizations such as Dana-Farber Cancer Institute Inc. and Ash Stevens, Inc. His work in these institutions has allowed him to further develop his research and contribute to advancements in cancer treatment.

Collaborations

Henry has collaborated with esteemed colleagues, including Andre Rosowsky and Peter Blumbergs. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Henry Bader's innovative work in the field of pharmaceuticals highlights his dedication to improving cancer treatment through his patented inventions. His contributions are a testament to the importance of research and collaboration in advancing medical science.